PURE Bioscience, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $334.0K | $349.0K | $1.1M | $3.4M | $2.4M | $3.8M | $398.0K | $851.0K |
| Accounts Receivable | $474.0K | $298.0K | $285.0K | $201.0K | $368.0K | $1.1M | $373.0K | $275.0K |
| Inventory | $141.0K | $56.0K | $88.0K | $179.0K | $332.0K | $547.0K | $177.0K | $197.0K |
| Total Current Assets | $1.0M | $805.0K | $1.6M | $3.9M | $3.2M | $5.6M | $1.0M | $1.5M |
| Property, Plant & Equipment | $11.0K | $13.0K | $221.0K | $620.0K | $740.0K | $316.0K | $362.0K | $461.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | $366.0K | $441.0K | $529.0K | $658.0K |
| Total Assets | $1.1M | $818.0K | $1.8M | $4.5M | $4.3M | $6.3M | $1.9M | $2.6M |
| Liabilities | ||||||||
| Accounts Payable | $784.0K | $601.0K | $422.0K | $488.0K | $593.0K | $1.3M | $553.0K | $608.0K |
| Total Current Liabilities | $938.0K | $733.0K | $532.0K | $575.0K | $970.0K | $1.5M | $738.0K | $1.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $6.2M | $3.7M | $1.6M | $575.0K | $970.0K | $1.5M | $742.0K | $1.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-139.0M | $-136.6M | $-133.2M | $-129.3M | $-125.8M | $-123.5M | $-123.5M | $-116.9M |
| Total Stockholders' Equity | $-5.1M | $-2.9M | $272.0K | $3.9M | $3.3M | $4.8M | $1.2M | $1.3M |